{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:39:08Z","timestamp":1768527548793,"version":"3.49.0"},"reference-count":34,"publisher":"Index Copernicus","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pol Przegl Chir"],"published-print":{"date-parts":[[2025,8,11]]},"abstract":"<ns3:p>&lt;b&gt;Introduction:&lt;\/b&gt; Caspases play a key role in apoptosis, the disruption of which can lead to the proliferation of abnormal cell clones and tumor growth. Caspases\u2019 role as potential biomarkers has been confirmed in relation to many types of cancer.&lt;b&gt;Aim:&lt;\/b&gt; In this study, the authors focused on the European population with an average incidence of gastric cancer to investigatethe importance of caspases in gastric cancer.&lt;b&gt;Material and methods:&lt;\/b&gt;  For this purpose, we evaluated the expression of representative caspases \u2013 an effector caspase-3 as well as caspase-8 and -9 initiating the apoptosis process, studying the cases of 53 patients who had been operated on in the Department of General Surgery and Surgical Oncology from 2010 to 2014. Also, we selected patients who had not received the neoadjuvant chemotherapy. An attempt was then made to identify correlations between caspase expression and clinical or pathological features of gastric cancers. The expression was evaluated by immunohistochemical reactions using monoclonal antibodies. Statistical analysis was performed, including parametric and nonparametric tests, like Kruskal-Wallis and Spearman's rho.&lt;b&gt;Results:&lt;\/b&gt; The study did not confirm a significant role of caspases in gastric cancer. We found no correlation with overall survival, tumor location, clinical stage, or its grade of histopathological malignancy as defined by World Health Organization (WHO). The possibility of using the selected caspases as biomarkers was not confirmed.&lt;b&gt;Discussion:&lt;\/b&gt;  Our observations are significantly different from those described in the literature. This may indicate differences in tumour biology in different patient populations.&lt;b&gt;Conclusions:&lt;\/b&gt; In the study performed by the authors of this paper, no correlation of caspase-3, -8, and -9 IRS score with clinicopathological factors and long-term survival was found to be statistically significant.<\/ns3:p>","DOI":"10.5604\/01.3001.0055.2379","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T10:56:24Z","timestamp":1767092184000},"page":"57-63","source":"Crossref","is-referenced-by-count":0,"title":["Caspases as a biomarker \u2013 similar or a different gastric cancer biology"],"prefix":"10.5604","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3392-2680","authenticated-orcid":false,"given":"Ewelina","family":"Frejlich","sequence":"first","affiliation":[{"name":"University Centre of General and Oncological Surgery, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3596-2990","authenticated-orcid":false,"given":"Przemys\u0142aw","family":"Prz\u0105dka","sequence":"additional","affiliation":[{"name":"Department and Clinic of Surgery, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Science, Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4240-7899","authenticated-orcid":false,"given":"Agnieszka","family":"Ha\u0142o\u0144","sequence":"additional","affiliation":[{"name":"Division of Clinical Pathology, Department of Clinical and Experimental Pathology, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3689","reference":[{"key":"631183r1","doi-asserted-by":"crossref","unstructured":"Sung H., Ferlay J., Siegel R.L. et al.: Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin., 2020; 71(3): 209\u2013249. doi: 10.3322\/caac.21660.","DOI":"10.3322\/caac.21660"},{"key":"631183r2","doi-asserted-by":"crossref","unstructured":"Bickenbach K., Strong V.E.: Comparisons of Gastric Cancer Treatments: Eastvs. West. J Gastric Cancer., 2012; 12(2): 55\u201362. doi: 10.5230\/jgc.2012.12.2.55.","DOI":"10.5230\/jgc.2012.12.2.55"},{"key":"631183r3","doi-asserted-by":"crossref","unstructured":"Russo A., Li P., Strong V.E.: Differences in the multimodal treatment of gastric cancer: East versus west. J Surg Oncol., 2017; 115(5): 603\u2013614. doi:10.1002\/jso.24517.","DOI":"10.1002\/jso.24517"},{"key":"631183r4","doi-asserted-by":"crossref","unstructured":"Chen Y.C., Fang W.L., Wang R.F. et al.: Clinicopathological Variation of Lauren Classification in Gastric Cancer. Pathol Oncol Res., 2016; 22(1): 197\u2013202.doi: 10.1007\/s12253-015-9996-6.","DOI":"10.1007\/s12253-015-9996-6"},{"key":"631183r5","doi-asserted-by":"crossref","unstructured":"Hamashima C.: The burden of gastric cancer. Ann Transl Med., 2020; 8(12): 734 doi: 10.21037\/atm.2020.03.166.","DOI":"10.21037\/atm.2020.03.166"},{"key":"631183r6","doi-asserted-by":"crossref","unstructured":"Chan W.L., Lam K.O., Lee V.H.F. et al.: Gastric Cancer \u2013 From Aetiology toManagement: Differences Between the East and the West. Clin Oncol (R CollRadiol)., 2019; 31(8): 570\u2013577. doi: 10.1016\/j.clon.2019.05.012.","DOI":"10.1016\/j.clon.2019.05.012"},{"key":"631183r7","unstructured":"The TNM classification of malignant tumours. 8th ed., eds.: J.D. Brierley, M.K.Gospodarowicz, C. Wittekind C. Wiley Blackwell, Oxford 2017."},{"key":"631183r8","doi-asserted-by":"crossref","unstructured":"Hanahan D., Weinberg R.A.: Hallmarks of cancer: the next generation. Cell.,2011; 144(5): 646\u2013674. doi: 10.1016\/j.cell.2011.02.013.","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"631183r9","doi-asserted-by":"crossref","unstructured":"Nagtegaal I.D., Odze R.D., Klimstra D. et al.: WHO Classification of TumoursEditorial Board. The 2019 WHO classification of tumours of the digestive system. Histopathology., 2020; 76(2): 182\u2013188. doi: 10.1111\/his.13975.","DOI":"10.1111\/his.13975"},{"key":"631183r10","doi-asserted-by":"crossref","unstructured":"Yang X., Zhong D.N., Qin H. et al.: Caspase-3 over-expression is associated with pooroverall survival and clinicopathological parameters in breast cancer: a meta-analysisof 3091 cases. Oncotarget., 2017; 9(9): 8629\u20138641. doi: 10.18632\/oncotarget.23667.","DOI":"10.18632\/oncotarget.23667"},{"key":"631183r11","doi-asserted-by":"crossref","unstructured":"Jonges L.E., Nagelkerke J.F., Ensink N.G. et al.: Caspase-3 activity as a prognostic factor in colorectal carcinoma. Lab Invest., 2001; 81(5): 681\u2013668. doi:10.1038\/labinvest.3780277.","DOI":"10.1038\/labinvest.3780277"},{"key":"631183r12","doi-asserted-by":"crossref","unstructured":"Pu X., Storr S.J., Zhang Y. et al.: Caspase-3 and caspase-8 expression in breastcancer: caspase-3 is associated with survival. Apoptosis., 2017; 22(3): 357\u2013368.doi: 10.1007\/s10495-016-1323-5.","DOI":"10.1007\/s10495-016-1323-5"},{"key":"631183r13","doi-asserted-by":"crossref","unstructured":"Pop C., Salvesen G.S.: Human Caspases: Activation, Specificity, and Regulation. Biol Chem., 2009; 284(33): 21777\u201321781. doi: 10.1074\/jbc.R800084200.","DOI":"10.1074\/jbc.R800084200"},{"key":"631183r14","doi-asserted-by":"crossref","unstructured":"Julien O., Wells J.A.: Caspases and their substrates. Cell Death Differ., 2017;24: 1380\u20131389. doi: 10.1038\/cdd.2017.44.","DOI":"10.1038\/cdd.2017.44"},{"key":"631183r15","unstructured":"Frejlich E., Rudno-Rudzi\u0144ska J., Janiszewski K. et al.: Caspases and their rolein gastric cancer. Adv Clin Exp Med., 2013; 22(4): 593\u2013602."},{"key":"631183r16","doi-asserted-by":"crossref","unstructured":"McIlwain D.R., Berger T., Mak T.W.: Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol., 2013; 5(4): a008656. doi: 10.1101\/cshperspect.a008656. Erratum in: Cold Spring Harb Perspect Biol., 2015; 7(4):a026716. doi: 10.1101\/cshperspect.a026716.","DOI":"10.1101\/cshperspect.a026716"},{"key":"631183r17","doi-asserted-by":"crossref","unstructured":"Remmele W., Schicketanz K.H.: Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer--assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol ResPract., 1993; 189(8): 862\u2013866. doi: 10.1016\/S0344-0338(11)81095-2.","DOI":"10.1016\/S0344-0338(11)81095-2"},{"key":"631183r18","unstructured":"Abbott M.L.: Using statistics in the social and health sciences with SPSS andExcel. John Wiley & Sons, Inc., Hoboken, New Jersey 2017."},{"key":"631183r19","doi-asserted-by":"crossref","unstructured":"Pfeffer C.M., Singh A.T.K.: Apoptosis: A Target for Anticancer Therapy. IntJ Mol Sci., 2018; 19(2): 448. doi: 10.3390\/ijms19020448.","DOI":"10.3390\/ijms19020448"},{"key":"631183r20","doi-asserted-by":"crossref","unstructured":"de Jong J., Diest P., Baak J.: Number of apoptotic cells as a prognostic marker in invasive breast cancer. Br J Cancer., 2000; 82(2): 368\u2013373. doi: 10.1054\/bjoc.1999.0928.","DOI":"10.1054\/bjoc.1999.0928"},{"key":"631183r21","doi-asserted-by":"crossref","unstructured":"Duiker E.W., van der Zee A.G., de Graeff P. et al.: The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer. Gynecol Oncol., 2010; 116(3):549\u2013555. doi: 10.1016\/j.ygyno.2009.09.014.","DOI":"10.1016\/j.ygyno.2009.09.014"},{"key":"631183r22","doi-asserted-by":"crossref","unstructured":"Lv R., Zhu M., Chen K. et al.: Z-Guggulsterone Induces Apoptosis in GastricCancer Cells through the Intrinsic Mitochondria-Dependent Pathway. ScientificWorldJournal., 2021; 2021: 3152304. doi: 10.1155\/2021\/3152304.","DOI":"10.1155\/2021\/3152304"},{"key":"631183r23","doi-asserted-by":"crossref","unstructured":"Olsson M., Zhivotovsky B.: Caspases and cancer. Cell Death Differ., 2011; 18(9):1441\u20131449. doi: 10.1038\/cdd.2011.30.","DOI":"10.1038\/cdd.2011.30"},{"key":"631183r24","doi-asserted-by":"crossref","unstructured":"Wang X., Fu Z., Chen Y., Liu L.: Fas expression is downregulated in gastriccancer. Mol Med Rep., 2017; 15(2): 627\u2013634. doi: 10.3892\/mmr.2016.6037.","DOI":"10.3892\/mmr.2016.6037"},{"key":"631183r25","doi-asserted-by":"crossref","unstructured":"Soung Y.H., Lee J.W., Kim S.Y. et al.: CASPASE-8 gene is inactivated by somaticmutations in gastric carcinomas. Cancer Res., 2005; 65(3): 815\u2013821.","DOI":"10.1158\/0008-5472.815.65.3"},{"key":"631183r26","doi-asserted-by":"crossref","unstructured":"Hashemi M., Aftabi S., Moazeni-Roodi A. et al.: Association of CASP8 polymorphisms and cancer susceptibility: A meta-analysis. Eur J Pharmacol., 2020;881: 173201. doi: 10.1016\/j.ejphar.2020.173201.","DOI":"10.1016\/j.ejphar.2020.173201"},{"key":"631183r27","doi-asserted-by":"crossref","unstructured":"Wang Z., Ni F., Yu F. et al.: Prognostic significance of mRNA expression ofCASPs in gastric cancer. Oncol Lett., 2019; 18(5): 4535\u20134554. doi: 10.3892\/ol.2019.10816.","DOI":"10.3892\/ol.2019.10816"},{"key":"631183r28","doi-asserted-by":"crossref","unstructured":"Yoo N.J., Kim H.S., Kim S.Y. et al.: Stomach cancer highly expresses both initiator and effector caspases; an immunohistochemical study. APMIS., 2002;110(11): 825\u2013832. doi: 10.1034\/j.1600-0463.2002.1101109.x.","DOI":"10.1034\/j.1600-0463.2002.1101109.x"},{"key":"631183r29","doi-asserted-by":"crossref","unstructured":"Yoo N.J., Lee S.H., Jeong E.G., Lee S.H.: Expression of phosphorylated caspase-9 in gastric carcinomas. APMIS., 2007; 115(4): 354\u2013359. doi: 10.1111\/j.1600-0463.2007.apm_632.x.","DOI":"10.1111\/j.1600-0463.2007.apm_632.x"},{"key":"631183r30","doi-asserted-by":"crossref","unstructured":"Amptoulach S., Lazaris A.C., Giannopoulou I. et al.: Expression of caspase-3predicts prognosis in advanced noncardia gastric cancer. Med Oncol., 2015;32(1): 416. doi: 10.1007\/s12032-014-0416-7.","DOI":"10.1007\/s12032-014-0416-7"},{"key":"631183r31","doi-asserted-by":"crossref","unstructured":"Huang K.H., Fang W.L., Li A.F. et al.: Caspase-3, a key apoptotic protein, as aprognostic marker in gastric cancer after curative surgery. Int J Surg., 2018;52: 258\u2013263. doi: 10.1016\/j.ijsu.2018.02.055.","DOI":"10.1016\/j.ijsu.2018.02.055"},{"key":"631183r32","unstructured":"Hu Q., Peng J., Liu W. et al.: Elevated cleaved caspase-3 is associated withshortened overall survival in several cancer types. Int J Clin Exp Pathol., 2014;7(8): 5057\u20135070."},{"key":"631183r33","unstructured":"Chen H., Yang X., Feng Z. et al.: Prognostic value of Caspase-3 expression incancers of digestive tract: a meta-analysis and systematic review. Int J Clin ExpMed., 2015; 8(7): 10225\u201310234."},{"key":"631183r34","doi-asserted-by":"crossref","unstructured":"Fu Y.G., Qu Y.J., Wu K.C. et al.: Apoptosis-inducing effect of recombinantCaspase-3 expressed by constructed eukaryotic vector on gastric cancer cellline SGC7901. World J Gastroenterol., 2003; 9(9): 1935\u20131939. doi: 10.3748\/wjg.v9.i9.1935.","DOI":"10.3748\/wjg.v9.i9.1935"}],"container-title":["Polish Journal of Surgery"],"original-title":[],"link":[{"URL":"https:\/\/ppch.pl\/gicid\/pdf\/01.3001.0055.2379","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ppch.pl\/gicid\/pdf\/01.3001.0055.2379","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:23:34Z","timestamp":1768469014000},"score":1,"resource":{"primary":{"URL":"https:\/\/ppch.pl\/gicid\/01.3001.0055.2379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.5604\/01.3001.0055.2379","relation":{},"ISSN":["0032-373X","2299-2847"],"issn-type":[{"value":"0032-373X","type":"print"},{"value":"2299-2847","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]}}}